"The U.S. Food and Drug Administration recently approved Oralair to treat allergic rhinitis (hay fever) with or without conjunctivitis (eye inflammation) that is induced by certain grass pollens in people ages 10 through 65 years. Oralair is the f"...
Histinex® HC (phenylephrine, hydrocodone, cpm) reduces excessive nasal secretions, diminishes edema of the nasal mucosa and congestion of the upper respiratory tract and abolishes or diminishes cough. The antihistaminic action of chlorpheniramine maleate reduces or abolishes allergenic responses of nasal tissue. Its action is complemented by the mild vasoconstrictor action of phenylephrine hydrochloride which provides a nasal decongestant effect. Cough suppression is a result of the action of hydrocodone bitartrate.
Last reviewed on RxList: 4/9/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Histinex HC Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Allergies & Asthma
Improve treatments & prevent attacks.